Vol 4, No 1 (2018)
Review paper
Published online: 2018-04-05
Etiologia i czynniki ryzyka rozwoju twardziny układowej — przegląd literatury
Forum Reumatol 2018;4(1):52-56.
Abstract
Twardzina układowa (SSc) jest rzadką chorobą autoimmunologiczną charakteryzującą się włóknieniem skóry oraz różnych narządów wewnętrznych. Wśród czynników etiologicznych dopatruje się zależności genetycznych oraz środowiskowych. Choroba częściej występuje u płci żeńskiej, osób eksponowanych na substancje toksyczne (związki krzemu, rozpuszczalniki organiczne, pestycydy, leki), a także w niektórych regionach geograficznych. W pracy przybliżono możliwe zależności etiologiczne oraz czynniki ryzyka zachorowania na twardzinę układową.
Forum Reumatol. 2018, tom 4, nr 1: 52–56
Keywords: twardzina układowaetiologiaczynniki ryzyka
References
- Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 2005; 26(11): 587–595.
- LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988; 15(2): 202–205.
- Reimer G, Steen VD, Penning CA, et al. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum. 1988; 31(4): 525–532.
- van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013; 72(11): 1747–1755.
- Chifflot H, Fautrel B, Sordet C, et al. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008; 37(4): 223–235.
- Kanecki K, Goryński P, Tarka P, et al. Incidence and prevalence of Systemic Sclerosis (SSc) in Poland - differences between rural and urban regions. Ann Agric Environ Med. 2017; 24(2): 240–244.
- Silman AJ. Epidemiology of scleroderma. Annals of the Rheumatic Diseases. 1991; 50(Supplement 4): 846–853.
- Nashid M, Khanna PP, Furst DE, et al. investigators of the D-penicillamine, human recombinant relaxin and oral bovine type I collagen clinical trials. Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials. Rheumatology (Oxford). 2011; 50(2): 335–342.
- Arnett FC, Cho M, Chatterjee S, et al. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum. 2001; 44(6): 1359–1362, doi: 10.1002/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S.
- Feghali-Bostwick C, Medsger TA, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 2003; 48(7): 1956–1963.
- Altorok N, Kahaleh B. Epigenetics and systemic sclerosis. Semin Immunopathol. 2015; 37(5): 453–462.
- Wei J, Melichian D, Komura K, et al. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum. 2011; 63(6): 1707–1717.
- Pollard KM. Silica, Silicosis, and Autoimmunity. Front Immunol. 2016; 7: 97.
- Yamamoto T. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis? Arch Dermatol Res. 2006; 297(8): 333–344.
- Nietert PJ, Sutherland SE, Silver RM, et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 1998; 41(6): 1111–1118, doi: 10.1002/1529-0131(199806)41:6<1111::AID-ART19>3.0.CO;2-J.
- Magnant J, de Monte M, Guilmot JL, et al. Relationship between occupational risk factors and severity markers of systemic sclerosis. J Rheumatol. 2005; 32(9): 1713–1718.
- Kettaneh A, Al Moufti O, Tiev KP, et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. J Rheumatol. 2007; 34(1): 97–103.
- Thompson AE, Pope JE. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol. 2002; 29(9): 1867–1873.
- Aida-Yasuoka K, Peoples C, Yasuoka H, et al. Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis. Arthritis Res Ther. 2013; 15(1): R10.
- Lambe M, Björnådal L, Neregård P, et al. Childbearing and the risk of scleroderma: a population-based study in Sweden. Am J Epidemiol. 2004; 159(2): 162–166.
- Cockrill T, del Junco DJ, Arnett FC, et al. Separate influences of birth order and gravidity/parity on the development of systemic sclerosis. Arthritis Care Res (Hoboken). 2010; 62(3): 418–424.
- Jimenez SA, Artlett CM. Microchimerism and systemic sclerosis. Curr Opin Rheumatol. 2005; 17(1): 86–90.
- ERASMUS LD. Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med. 1957; 3(3): 209–231.
- Marie I, Gehanno JF. Environmental risk factors of systemic sclerosis. Semin Immunopathol. 2015; 37(5): 463–473.
- Rubio-Rivas M, Moreno R, Corbella X. Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin Rheumatol. 2017; 36(3): 569–582.
- Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med. 2000; 342(11): 781–790.
- Marie I, Gehanno JF, Bubenheim M, et al. Systemic sclerosis and exposure to heavy metals: A case control study of 100 patients and 300 controls. Autoimmun Rev. 2017; 16(3): 223–230.
- Mora GF. Systemic sclerosis: environmental factors. J Rheumatol. 2009; 36(11): 2383–2396.
- Wilson R. Occupational Acroosteolysis. JAMA. 1967; 201(8): 577–581.
- Läuchli S, Trüeb RM, Fehr M, et al. Scleroderma-like drug reaction to paclitaxel (Taxol). Br J Dermatol. 2002; 147(3): 619–621.
- Aeschlimann A, de Truchis P, Kahn MF. Scleroderma after therapy with appetite suppressants. Report on four cases. Scand J Rheumatol. 1990; 19(1): 87–90.
- Silman AJ, Howard Y, Hicklin AJ, et al. Geographical clustering of scleroderma in south and west London. Br J Rheumatol. 1990; 29(2): 93–96.
- Roberts-Thomson PJ, Jones M, Hakendorf P, et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J. 2001; 31(4): 220–229.
- Lo Monaco A, Bruschi M, La Corte R, et al. Epidemiology of systemic sclerosis in a district of northern Italy. Clin Exp Rheumatol. 2011; 29(2 Suppl 65): S10–S14.
